Cell Source, Inc. Conversion of Stock, Shares Converted
Cell Source, Inc. (CLCS) reported Conversion of Stock, Shares Converted of 87.67 thousand shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-12-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-12-08
- Cell Source, Inc. conversion of stock, shares converted for the quarter ending 2022-09-30 was 5.18K shares.
- Cell Source, Inc. conversion of stock, shares converted for the quarter ending 2022-06-30 was 5.96K shares.
- Cell Source, Inc. conversion of stock, shares converted for the quarter ending 2022-03-31 was 76.53K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2022-09-30 | 5.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-08 | 11.14K shares derived: sum of 2 quarters · filed 2022-12-08 | 87.67K shares 10-Q · filed 2022-12-08 | |
| 2022-06-30 | 5.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-02 | 82.49K shares 10-Q · filed 2022-12-02 | ||
| 2022-03-31 | 76.53K shares 10-Q · filed 2022-11-02 | |||
| 2014-12-31 | 193.33K shares 10-Q · filed 2015-11-16 |